Angiogenesis Induced in the Elderly by Hyperbaric Oxygen Therapy
NCT: NCT02790541 · COMPLETED
Brief Summary
Recent studies show preliminary evidence of HBOT therapeutic effects on angiogenesis, increased tissue blood flow and oxygenation correlated with tissue function. Our primary hypothesis is that HBOT will have beneficial effects on the above mentioned organs associated with aging-related malfunctions due to restored mitochondrial function, mobilization of stem cells and induction of angiogenesis.
Frequently Asked Questions
What is Angiogenesis Induced in the Elderly by Hyperbaric Oxygen Therapy?
Angiogenesis Induced in the Elderly by Hyperbaric Oxygen Therapy is a clinical trial registered under NCT02790541. Current status: COMPLETED.
What is the status of NCT02790541?
The current status of NCT02790541 (Angiogenesis Induced in the Elderly by Hyperbaric Oxygen Therapy) is: COMPLETED.
When did Angiogenesis Induced in the Elderly by Hyperbaric Oxygen Therapy start?
Angiogenesis Induced in the Elderly by Hyperbaric Oxygen Therapy started on 2016-12.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.